erythrocytosis; testosterone; hematocrit; trt

https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/clinem/dgae434/7697829?redirectedFrom=fulltext&login=false Conclusions We conclude that hypogonadal men have reduced erythrocyte lifespan and acute androgen-induced increase in circulating erythrocyte lifespan may contribute...

ABSTRACT Objective Elevated hematocrit (Hct) can result in increased risk of major adverse cardiac events(MACE) in men receiving testosterone therapy (TTh). However, the impact of the magnitude of the change in Hct from baseline after starting TTh has never been assessed. Methods To assess...

Shane M. Kelleher, *InfiniT Men’s Health Clinic, Burleson, TX76028, USA Abstract The goal of this study was to determine how to minimize the secondary polycythemia effect observed in patients on testosterone replacement therapy (TRT). Patient hemoglobin, estradiol (E2), and total...

Prevalence of secondary erythrocytosis in men receiving testosterone therapy: A matched cohort analysis of intranasal gel, injections, and pellets (2023) Rohit Reddy*, Parris Diaz*, Ruben Blachman-Braun, Justin Loloi, Farah Rahman, Jesse Ory, Alexandra Dullea, Isaac Zucker, Daniel C. Gonzalez...